首页 > 最新文献

European Medical Journal最新文献

英文 中文
Climate Change and Air Pollution: How Healthcare Providers Can Help Mitigate the Risks to Respiratory Health 气候变化与空气污染:医疗服务提供者如何帮助降低呼吸系统健康风险
Pub Date : 2024-06-13 DOI: 10.33590/emj/juyj2358
Fan Chung, Gary Wong, Sundeep Salvi, Christopher Carlsten
{"title":"Climate Change and Air Pollution: How Healthcare Providers Can Help Mitigate the Risks to Respiratory Health","authors":"Fan Chung, Gary Wong, Sundeep Salvi, Christopher Carlsten","doi":"10.33590/emj/juyj2358","DOIUrl":"https://doi.org/10.33590/emj/juyj2358","url":null,"abstract":"","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141349125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fever, Sore Throat, and Abdominal Pain – Connecting the Dots to a ‘Forgotten’ Disease: A Case Report of Atypical Lemierre’s Syndrome 发热、喉咙痛和腹痛--与一种 "被遗忘 "疾病的关联:非典型勒米尔氏综合征病例报告
Pub Date : 2024-06-13 DOI: 10.33590/emj/whtd3554.
Taniya Yasmin, Sara Glazer, Breanna A. Chen, Farah Abdulsatar
Lemierre’s syndrome (LS) is a rare but potentially life-threatening condition resulting from oropharyngeal infections. It is characterised by septic thrombophlebitis of the internal jugular vein and disseminated metastatic abscesses. However, atypical presentations with unusual sites of thrombosis and spread have been reported. The authors present a case of LS with an atypical presentation in a previously healthy 17-year-old male. This case highlights the need for a high level of suspicion, and comprehensive investigation in cases of unexplained sepsis following oropharyngeal infections, as LS can have atypical presentations and potentially life-threatening complications. The traditional definition of LS may need to be re-evaluated in light of such atypical manifestations.
勒米尔综合征(Lemierre's Syndrome,LS)是一种罕见但可能危及生命的口咽部感染病。其特征是颈内静脉化脓性血栓性静脉炎和播散转移性脓肿。不过,也有非典型表现,血栓形成和扩散部位不寻常的报道。作者介绍了一例以前健康的 17 岁男性 LS 非典型表现病例。该病例强调,在口咽部感染后出现不明原因的败血症时,需要高度怀疑并进行全面检查,因为LS可能有非典型表现和潜在的危及生命的并发症。鉴于这种非典型表现,LS的传统定义可能需要重新评估。
{"title":"Fever, Sore Throat, and Abdominal Pain – Connecting the Dots to a ‘Forgotten’ Disease: A Case Report of Atypical Lemierre’s Syndrome","authors":"Taniya Yasmin, Sara Glazer, Breanna A. Chen, Farah Abdulsatar","doi":"10.33590/emj/whtd3554.","DOIUrl":"https://doi.org/10.33590/emj/whtd3554.","url":null,"abstract":"Lemierre’s syndrome (LS) is a rare but potentially life-threatening condition resulting from oropharyngeal infections. It is characterised by septic thrombophlebitis of the internal jugular vein and disseminated metastatic abscesses. However, atypical presentations with unusual sites of thrombosis and spread have been reported. The authors present a case of LS with an atypical presentation in a previously healthy 17-year-old male. This case highlights the need for a high level of suspicion, and comprehensive investigation in cases of unexplained sepsis following oropharyngeal infections, as LS can have atypical presentations and potentially life-threatening complications. The traditional definition of LS may need to be re-evaluated in light of such atypical manifestations.","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review of the 12th Edition of the European Conference on Rare Diseases and Orphan Products (ECRD) 2024 第 12 届欧洲罕见病与孤儿产品大会(ECRD)回顾 2024 年
Pub Date : 2024-06-13 DOI: 10.33590/emj/wsst7298
Emj
{"title":"Review of the 12th Edition of the European Conference on Rare Diseases and Orphan Products (ECRD) 2024","authors":"Emj","doi":"10.33590/emj/wsst7298","DOIUrl":"https://doi.org/10.33590/emj/wsst7298","url":null,"abstract":"","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346032","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Penile Skin Bridge: Uncommon Cause of Painful Spontaneous Erection in Young Males 阴茎皮肤桥:年轻男性自发勃起疼痛的罕见原因
Pub Date : 2024-06-13 DOI: 10.33590/emj/hybw6733
A.O. Takure
Erection is a neurovascular response to visual, emotional, and tactile stimuli. It is classified as psychogenic, reflexogenic, and nocturnal. The causes of painful erections are Peyronie’s disease, penile fracture, penile tumours, penile lichen sclerosis, and a rare disorder called sleep-related painful erection syndrome. Here, the authors report six cases of painful spontaneous erection due to penile skin bridges in young males, seen between 2021–2023. They analysed the age, clinical features, treatment offered, and outcome at 3 months post-surgery. Patients’ mean age was 20.5 years (range: 13–35 years), and the haemoglobin genotype was AA. Two males had associated yellowish discharges under the skin bridges. They all had excision of the skin bridges with satisfactory post-operative appearance, and no pain with erection. Penile skin bridge is an uncommon cause of painful penile erection, and the authors recommend that all general practitioners be aware of this entity, and keep it in mind during a thorough physical examination.
勃起是神经血管对视觉、情感和触觉刺激的反应。它分为精神性、反射性和夜间性。引起疼痛性勃起的原因包括佩罗尼氏病、阴茎骨折、阴茎肿瘤、阴茎苔藓硬化症以及一种罕见的疾病--睡眠相关性疼痛性勃起综合征。在此,作者报告了六例在 2021-2023 年间发生的年轻男性阴茎皮肤桥导致的自发勃起疼痛病例。他们分析了患者的年龄、临床特征、治疗方法以及术后 3 个月的结果。患者的平均年龄为 20.5 岁(范围:13-35 岁),血红蛋白基因型为 AA。两名男性患者的皮肤桥下伴有淡黄色分泌物。他们都切除了皮桥,术后外观令人满意,勃起时也没有疼痛感。阴茎皮桥是导致阴茎勃起疼痛的一个不常见原因,作者建议所有全科医生都要注意这种情况,并在进行全面体检时牢记这一点。
{"title":"Penile Skin Bridge: Uncommon Cause of Painful Spontaneous Erection in Young Males","authors":"A.O. Takure","doi":"10.33590/emj/hybw6733","DOIUrl":"https://doi.org/10.33590/emj/hybw6733","url":null,"abstract":"Erection is a neurovascular response to visual, emotional, and tactile stimuli. It is classified as psychogenic, reflexogenic, and nocturnal. The causes of painful erections are Peyronie’s disease, penile fracture, penile tumours, penile lichen sclerosis, and a rare disorder called sleep-related painful erection syndrome. Here, the authors report six cases of painful spontaneous erection due to penile skin bridges in young males, seen between 2021–2023. They analysed the age, clinical features, treatment offered, and outcome at 3 months post-surgery. Patients’ mean age was 20.5 years (range: 13–35 years), and the haemoglobin genotype was AA. Two males had associated yellowish discharges under the skin bridges. They all had excision of the skin bridges with satisfactory post-operative appearance, and no pain with erection. Penile skin bridge is an uncommon cause of painful penile erection, and the authors recommend that all general practitioners be aware of this entity, and keep it in mind during a thorough physical examination.","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frequency Determination of Central Line Associated Bloodstream Infection at a Renal Care Centre 肾脏护理中心中心管相关血流感染的频率测定
Pub Date : 2024-06-13 DOI: 10.33590/emj/jpqb3019
Safia Moin, Bina Salman, Aasim Ahmad
Background: Central line-associated bloodstream infection (CLABSI) is a serious infection typically increasing morbidity and mortality in patients with chronic kidney disease (CKD). It can be prevented through proper insertion techniques and management of the central line (CL). However, the first step in reducing the CLABSI rate is to define the extent of the problem through proper surveillance. This study aimed to determine the frequency of CLABSI in patients with CKD at a specialised renal care centre.Methods: The authors conducted a retrospective observational study to determine the frequency of CLABSI in patients with CKD between November 2021–September 2022 at their institute. They included all patients with CLs registered at their institute. Primary CLABSI was defined as CLABSI attributable to their hospital, while secondary CLABSI was defined as those not attributed to their hospital.Results: Fifty-nine incidences of CLABSI were identified in a total of 310 patients with CL and 1,413 CL days, giving a total of 42 CLABSI incidences per 1,000 CL days. Primary CLABSI was more common (n=36 [61%]) than secondary CLABSI (n=23 [39%]). Most of the patients recovered (53 [89.8%]); however, four (6.9%) patients expired. Most of the patients who recovered had permanent vascular access (n=32 [60.4%]), internal jugular placement (n=44 [83%]), and primary CLABSI (n=33 [62.3%]), although the p-values were non-significant.Conclusion: Strict implementation of CLABSI prevention bundles for line insertion and its maintenance and regular surveillance using laboratory confirmed cases is needed to reduce the rates of CLABSI.
背景:中心管路相关血流感染(CLABSI)是一种严重的感染,通常会增加慢性肾病(CKD)患者的发病率和死亡率。通过正确的插入技术和中心管路(CL)管理可以预防这种感染。然而,降低 CLABSI 感染率的第一步是通过适当的监测来确定问题的严重程度。本研究旨在确定一家专业肾脏护理中心的慢性肾脏病患者发生 CLABSI 的频率:作者开展了一项回顾性观察研究,以确定 2021 年 11 月至 2022 年 9 月期间其所在医院的慢性肾脏病患者发生 CLABSI 的频率。他们纳入了在其研究所登记的所有 CL 患者。原发性 CLABSI 被定义为归因于其医院的 CLABSI,而继发性 CLABSI 被定义为非归因于其医院的 CLABSI:在 310 名 CL 患者和 1,413 个 CL 日中发现了 59 例 CLABSI,即每 1,000 个 CL 日中有 42 例 CLABSI。原发性 CLABSI(36 例 [61%])比继发性 CLABSI(23 例 [39%])更常见。大多数患者都痊愈了(53 [89.8%]),但也有四名患者(6.9%)死亡。大多数痊愈患者拥有永久性血管通路(32 人 [60.4%])、颈内静脉置管(44 人 [83%])和原发性 CLABSI(33 人 [62.3%]),但 p 值不显著:结论:为降低 CLABSI 感染率,需要在置管及其维护过程中严格执行 CLABSI 预防措施,并利用实验室确诊病例进行定期监测。
{"title":"Frequency Determination of Central Line Associated Bloodstream Infection at a Renal Care Centre","authors":"Safia Moin, Bina Salman, Aasim Ahmad","doi":"10.33590/emj/jpqb3019","DOIUrl":"https://doi.org/10.33590/emj/jpqb3019","url":null,"abstract":"Background: Central line-associated bloodstream infection (CLABSI) is a serious infection typically increasing morbidity and mortality in patients with chronic kidney disease (CKD). It can be prevented through proper insertion techniques and management of the central line (CL). However, the first step in reducing the CLABSI rate is to define the extent of the problem through proper surveillance. This study aimed to determine the frequency of CLABSI in patients with CKD at a specialised renal care centre.\u0000\u0000Methods: The authors conducted a retrospective observational study to determine the frequency of CLABSI in patients with CKD between November 2021–September 2022 at their institute. They included all patients with CLs registered at their institute. Primary CLABSI was defined as CLABSI attributable to their hospital, while secondary CLABSI was defined as those not attributed to their hospital.\u0000\u0000Results: Fifty-nine incidences of CLABSI were identified in a total of 310 patients with CL and 1,413 CL days, giving a total of 42 CLABSI incidences per 1,000 CL days. Primary CLABSI was more common (n=36 [61%]) than secondary CLABSI (n=23 [39%]). Most of the patients recovered (53 [89.8%]); however, four (6.9%) patients expired. Most of the patients who recovered had permanent vascular access (n=32 [60.4%]), internal jugular placement (n=44 [83%]), and primary CLABSI (n=33 [62.3%]), although the p-values were non-significant.\u0000\u0000Conclusion: Strict implementation of CLABSI prevention bundles for line insertion and its maintenance and regular surveillance using laboratory confirmed cases is needed to reduce the rates of CLABSI.","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141345159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Role of Nebulisers in the Treatment of Patients with Severe and Very Severe Chronic Obstructive Pulmonary Disease 雾化器在治疗重度和极重度慢性阻塞性肺病患者中的作用
Pub Date : 2024-06-13 DOI: 10.33590/emj/uxua8923
Omar Usmani
{"title":"Role of Nebulisers in the Treatment of Patients with Severe and Very Severe Chronic Obstructive Pulmonary Disease","authors":"Omar Usmani","doi":"10.33590/emj/uxua8923","DOIUrl":"https://doi.org/10.33590/emj/uxua8923","url":null,"abstract":"","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346132","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lost in the System: The Labyrinth of Rare Disease Diagnosis 迷失在系统中罕见病诊断的迷宫
Pub Date : 2024-06-13 DOI: 10.33590/emj/dlph7436
Peter Fish
{"title":"Lost in the System: The Labyrinth of Rare Disease Diagnosis","authors":"Peter Fish","doi":"10.33590/emj/dlph7436","DOIUrl":"https://doi.org/10.33590/emj/dlph7436","url":null,"abstract":"","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
How Can We Bridge the Rare Disease Treatment Gap? 如何缩小罕见病治疗差距?
Pub Date : 2024-06-13 DOI: 10.33590/emj/hwfd3106
Darcy Richards
{"title":"How Can We Bridge the Rare Disease Treatment Gap?","authors":"Darcy Richards","doi":"10.33590/emj/hwfd3106","DOIUrl":"https://doi.org/10.33590/emj/hwfd3106","url":null,"abstract":"","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346104","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treatment of Dermatitis Artefacta: A Systematic Review 皮炎的治疗:系统综述
Pub Date : 2024-06-13 DOI: 10.33590/emj/anag6061
Mariah C. Estill, Mohammad Jafferany
Dermatitis artefacta (DA) is a rare psychocutaneous disorder characterised by self-inflicted skin lesions that the patient denies producing. DA poses a complex clinical challenge to clinicians as patients often are resistant to the diagnosis, and can be hesitant to follow up with psychiatric or psychological services. There is a need to understand the optimal approach for management of patients with DA. This systematic review was undertaken to address this gap in knowledge.A search was conducted on PubMed and Embase using the following search strategy: Dermatitis artefacta OR factitious dermatitis OR factitial dermatitis OR artefactual skin AND treatment OR management OR therapy OR psychotherapy OR pharmacotherapy. Included studies were published from inception to 5ᵗʰ April 2023 in peer-reviewed journals, and discussed the treatment and management of DA. Studies were excluded if they were published in a language other than English.A total of 11 retrospective or prospective studies were included in this systematic review. They all found DA to be challenging to treat, with every study reporting patients experiencing a comorbid psychiatric condition or associated psychosocial stressor. Overall, there were better reported outcomes among follow-up patients treated in psychodermatology clinics with multidisciplinary teams of dermatologists, psychiatrists, and psychologists.Medical treatments can help with symptom control and promote wound healing, while psychological and psychiatric treatments can help address underlying psychosocial stressors for the condition. Further research is needed to evaluate optimal management and long-term treatment outcomes in patients with DA.
伪装性皮炎(DA)是一种罕见的皮肤心理疾病,其特征是患者否认是自己造成的皮肤损伤。皮炎给临床医生带来了复杂的临床挑战,因为患者通常对诊断有抵触情绪,对精神或心理服务的后续治疗也会犹豫不决。我们需要了解治疗 DA 患者的最佳方法。本系统性综述旨在填补这一知识空白:在 PubMed 和 Embase 上使用以下检索策略进行了检索:假性皮炎 OR 假性皮炎 OR 假性皮炎 OR 假性皮炎 OR 假性皮肤 AND 治疗 OR 管理 OR 治疗 OR 心理治疗 OR 药物治疗。纳入的研究均发表于同行评审期刊上,时间从开始至 2023 年 4 月 5 日,并讨论了皮炎的治疗和管理。本系统综述共纳入了 11 项回顾性或前瞻性研究。这些研究都发现DA的治疗具有挑战性,每项研究都报告了患者合并有精神疾病或相关的社会心理压力。总体而言,在由皮肤科医生、精神科医生和心理学家组成的多学科团队的精神皮肤病诊所接受治疗的随访患者的疗效较好。医学治疗有助于控制症状和促进伤口愈合,而心理和精神治疗则有助于解决该病症的潜在社会心理压力。需要进一步开展研究,以评估对 DA 患者的最佳管理和长期治疗效果。
{"title":"Treatment of Dermatitis Artefacta: A Systematic Review","authors":"Mariah C. Estill, Mohammad Jafferany","doi":"10.33590/emj/anag6061","DOIUrl":"https://doi.org/10.33590/emj/anag6061","url":null,"abstract":"Dermatitis artefacta (DA) is a rare psychocutaneous disorder characterised by self-inflicted skin lesions that the patient denies producing. DA poses a complex clinical challenge to clinicians as patients often are resistant to the diagnosis, and can be hesitant to follow up with psychiatric or psychological services. There is a need to understand the optimal approach for management of patients with DA. This systematic review was undertaken to address this gap in knowledge.\u0000\u0000A search was conducted on PubMed and Embase using the following search strategy: Dermatitis artefacta OR factitious dermatitis OR factitial dermatitis OR artefactual skin AND treatment OR management OR therapy OR psychotherapy OR pharmacotherapy. Included studies were published from inception to 5ᵗʰ April 2023 in peer-reviewed journals, and discussed the treatment and management of DA. Studies were excluded if they were published in a language other than English.\u0000\u0000A total of 11 retrospective or prospective studies were included in this systematic review. They all found DA to be challenging to treat, with every study reporting patients experiencing a comorbid psychiatric condition or associated psychosocial stressor. Overall, there were better reported outcomes among follow-up patients treated in psychodermatology clinics with multidisciplinary teams of dermatologists, psychiatrists, and psychologists.\u0000\u0000Medical treatments can help with symptom control and promote wound healing, while psychological and psychiatric treatments can help address underlying psychosocial stressors for the condition. Further research is needed to evaluate optimal management and long-term treatment outcomes in patients with DA.","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141346841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nipah Virus in Kerala, India – Unravelling the Local Outbreak and Assessing Global Threats: A Narrative Review 印度喀拉拉邦的尼帕病毒--揭示当地疫情和评估全球威胁:叙事回顾
Pub Date : 2024-06-13 DOI: 10.33590/emj/ilfc3139
M. G. Gopika, Raj Mohan, Sayan Roy
The recent emergence of the Nipah virus in the same district of Kozhikode, India, following its outbreak in 2018 and 2021, has elicited heightened apprehension among the public amidst the era of COVID-19. The potential fatality associated with this virus has been effectively mitigated through mass awareness, community and healthcare involvement, and stringent implementation of preventive measures. Nevertheless, the rate of transmission has consistently escalated over a span of several years, suggesting an emerging potential for global public health implications. Although the transmission rate remains low, the elevated mortality linked to the Nipah virus constitutes a potential threat, accentuated by the absence of vaccines and dependable treatments, thereby underscoring the risk to public health and emphasising the necessity for proactive measures to protect the wellbeing of the community. This narrative review provides an overview of the Nipah outbreaks in Kerala, India, and its global impact by conducting a thorough search of databases such as PubMed, Google Scholar, and ResearchGate using the following keywords: “Nipah virus,” “Henipavirus,” and “Kerala.”
继 2018 年和 2021 年爆发尼帕病毒之后,最近在印度科济科德的同一地区又出现了尼帕病毒,在 COVID-19 时代引起了公众的高度担忧。通过大众宣传、社区和医疗机构的参与以及严格执行预防措施,该病毒可能造成的死亡已得到有效缓解。然而,几年来传播率持续上升,这表明该病毒有可能对全球公共卫生产生影响。虽然传播率仍然很低,但尼帕病毒导致的死亡率升高构成了潜在威胁,而疫苗和可靠治疗方法的缺乏又加剧了这一威胁,从而凸显了公共卫生面临的风险,并强调了采取积极措施保护社区福祉的必要性。本叙述性综述通过使用以下关键词对 PubMed、Google Scholar 和 ResearchGate 等数据库进行全面搜索,概述了印度喀拉拉邦爆发的尼帕疫情及其全球影响:"尼帕病毒"、"Henipavirus "和 "喀拉拉邦"。
{"title":"Nipah Virus in Kerala, India – Unravelling the Local Outbreak and Assessing Global Threats: A Narrative Review","authors":"M. G. Gopika, Raj Mohan, Sayan Roy","doi":"10.33590/emj/ilfc3139","DOIUrl":"https://doi.org/10.33590/emj/ilfc3139","url":null,"abstract":"The recent emergence of the Nipah virus in the same district of Kozhikode, India, following its outbreak in 2018 and 2021, has elicited heightened apprehension among the public amidst the era of COVID-19. The potential fatality associated with this virus has been effectively mitigated through mass awareness, community and healthcare involvement, and stringent implementation of preventive measures. Nevertheless, the rate of transmission has consistently escalated over a span of several years, suggesting an emerging potential for global public health implications. Although the transmission rate remains low, the elevated mortality linked to the Nipah virus constitutes a potential threat, accentuated by the absence of vaccines and dependable treatments, thereby underscoring the risk to public health and emphasising the necessity for proactive measures to protect the wellbeing of the community. This narrative review provides an overview of the Nipah outbreaks in Kerala, India, and its global impact by conducting a thorough search of databases such as PubMed, Google Scholar, and ResearchGate using the following keywords: “Nipah virus,” “Henipavirus,” and “Kerala.”","PeriodicalId":505023,"journal":{"name":"European Medical Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141349156","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
European Medical Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1